LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
about
LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
LGR5 rs17109924 is a predictiv ...... l-based adjuvant chemotherapy.
@ast
LGR5 rs17109924 is a predictiv ...... l-based adjuvant chemotherapy.
@en
type
label
LGR5 rs17109924 is a predictiv ...... l-based adjuvant chemotherapy.
@ast
LGR5 rs17109924 is a predictiv ...... l-based adjuvant chemotherapy.
@en
prefLabel
LGR5 rs17109924 is a predictiv ...... l-based adjuvant chemotherapy.
@ast
LGR5 rs17109924 is a predictiv ...... l-based adjuvant chemotherapy.
@en
P2093
P2860
P356
P1476
LGR5 rs17109924 is a predictiv ...... l-based adjuvant chemotherapy.
@en
P2093
A Berghold
H Samonigg
J Szkandera
M Asslaber
R Schaberl-Moser
P2860
P2888
P304
P356
10.1038/TPJ.2015.2
P577
2015-02-10T00:00:00Z
P5875
P6179
1040184620